[HTML][HTML] Current clinical trial status and future prospects of PPAR-targeted drugs for treating nonalcoholic fatty liver disease
S Kamata, A Honda, I Ishii - Biomolecules, 2023 - mdpi.com
The number of patients with nonalcoholic fatty liver disease (NAFLD)/nonalcoholic
steatohepatitis (NASH) is increasing globally and is raising serious concerns regarding the …
steatohepatitis (NASH) is increasing globally and is raising serious concerns regarding the …
[HTML][HTML] Current Clinical Trial Status and Future Prospects of PPAR-Targeted Drugs for Treating Nonalcoholic Fatty Liver Disease
S Kamata, A Honda, I Ishii - Biomolecules, 2023 - ncbi.nlm.nih.gov
The number of patients with nonalcoholic fatty liver disease (NAFLD)/nonalcoholic
steatohepatitis (NASH) is increasing globally and is raising serious concerns regarding the …
steatohepatitis (NASH) is increasing globally and is raising serious concerns regarding the …
Current Clinical Trial Status and Future Prospects of PPAR-Targeted Drugs for Treating Nonalcoholic Fatty Liver Disease.
S Kamata, A Honda, I Ishii - Biomolecules, 2023 - go.gale.com
The number of patients with nonalcoholic fatty liver disease (NAFLD)/nonalcoholic
steatohepatitis (NASH) is increasing globally and is raising serious concerns regarding the …
steatohepatitis (NASH) is increasing globally and is raising serious concerns regarding the …
Current Clinical Trial Status and Future Prospects of PPAR-Targeted Drugs for Treating Nonalcoholic Fatty Liver Disease.
S Kamata, A Honda, I Ishii - Biomolecules, 2023 - europepmc.org
The number of patients with nonalcoholic fatty liver disease (NAFLD)/nonalcoholic
steatohepatitis (NASH) is increasing globally and is raising serious concerns regarding the …
steatohepatitis (NASH) is increasing globally and is raising serious concerns regarding the …
[PDF][PDF] Current Clinical Trial Status and Future Prospects of PPAR-Targeted Drugs for Treating Nonalcoholic Fatty Liver Disease. Biomolecules 2023, 13, 1264
S Kamata, A Honda, I Ishii - 2023 - jinsoolim.com
The number of patients with nonalcoholic fatty liver disease (NAFLD)/nonalcoholic
steatohepatitis (NASH) is increasing globally and is raising serious concerns regarding the …
steatohepatitis (NASH) is increasing globally and is raising serious concerns regarding the …
Current Clinical Trial Status and Future Prospects of PPAR-Targeted Drugs for Treating Nonalcoholic Fatty Liver Disease
S Kamata, A Honda, I Ishii - Biomolecules, 2023 - pubmed.ncbi.nlm.nih.gov
The number of patients with nonalcoholic fatty liver disease (NAFLD)/nonalcoholic
steatohepatitis (NASH) is increasing globally and is raising serious concerns regarding the …
steatohepatitis (NASH) is increasing globally and is raising serious concerns regarding the …
Current Clinical Trial Status and Future Prospects of PPAR-Targeted Drugs for Treating Nonalcoholic Fatty Liver Disease
S Kamata, A Honda, I Ishii - Biomolecules, 2023 - search.proquest.com
The number of patients with nonalcoholic fatty liver disease (NAFLD)/nonalcoholic
steatohepatitis (NASH) is increasing globally and is raising serious concerns regarding the …
steatohepatitis (NASH) is increasing globally and is raising serious concerns regarding the …
Current Clinical Trial Status and Future Prospects of PPAR-Targeted Drugs for Treating Nonalcoholic Fatty Liver Disease.
S Kamata, A Honda, I Ishii - Biomolecules (2218-273X), 2023 - search.ebscohost.com
The number of patients with nonalcoholic fatty liver disease (NAFLD)/nonalcoholic
steatohepatitis (NASH) is increasing globally and is raising serious concerns regarding the …
steatohepatitis (NASH) is increasing globally and is raising serious concerns regarding the …
Current Clinical Trial Status and Future Prospects of PPAR-Targeted Drugs for Treating Nonalcoholic Fatty Liver Disease
Biomolecules, 2023 - europepmc.org
The number of patients with nonalcoholic fatty liver disease (NAFLD)/nonalcoholic
steatohepatitis (NASH) is increasing globally and is raising serious concerns regarding the …
steatohepatitis (NASH) is increasing globally and is raising serious concerns regarding the …